InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
0.8532
+0.0106 (1.26%)
Sep 4, 2026, 10:15 AM EDT - Market open
InspireMD Revenue
InspireMD had revenue of $1.77M in the quarter ending June 30, 2026, a decrease of -0.39%. This brings the company's revenue in the last twelve months to $10.84M, up 53.42% year-over-year. In the year 2025, InspireMD had annual revenue of $8.98M with 28.11% growth.
Revenue (ttm)
$10.84M
Revenue Growth
+53.42%
P/S Ratio
3.61
Revenue / Employee
$85,362
Employees
127
Market Cap
39.66M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.98M | 1.97M | 28.11% |
| Dec 31, 2024 | 7.01M | 804.00K | 12.96% |
| Dec 31, 2023 | 6.21M | 1.03M | 20.00% |
| Dec 31, 2022 | 5.17M | 676.00K | 15.04% |
| Dec 31, 2021 | 4.50M | 2.01M | 80.89% |
| Dec 31, 2020 | 2.49M | -1.24M | -33.22% |
| Dec 31, 2019 | 3.72M | 120.00K | 3.33% |
| Dec 31, 2018 | 3.60M | 840.00K | 30.42% |
| Dec 31, 2017 | 2.76M | 867.00K | 45.78% |
| Dec 31, 2016 | 1.89M | -416.00K | -18.01% |
| Dec 31, 2015 | 2.31M | -508.00K | -18.03% |
| Dec 31, 2014 | 2.82M | -2.06M | -42.17% |
| Jun 30, 2013 | 4.87M | -476.00K | -8.90% |
| Jun 30, 2012 | 5.35M | -655.00K | -10.91% |
| Dec 31, 2011 | 6.00M | 1.06M | 21.32% |
| Dec 31, 2010 | 4.95M | 1.54M | 45.09% |
| Dec 31, 2009 | 3.41M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 401.95M |
| Nortech Systems | 124.65M |
| TELA Bio | 79.91M |
| SANUWAVE Health | 44.02M |
| QT Imaging Holdings | 26.43M |
| Baird Medical Investment Holdings | 22.54M |
| Spectral AI | 15.39M |
| Nano-X Imaging | 14.52M |
NSPR News
- 1 day ago - InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 18 days ago - InspireMD Earnings Call Transcript: Q2 2026 - Transcripts
- 18 days ago - InspireMD Quarterly report: Q2 2026 - Filings
- 18 days ago - InspireMD Earnings release: Q2 2026 - Filings
- 18 days ago - InspireMD reports Q2 EPS (17c), consensus (19c) - TheFly
- 18 days ago - InspireMD Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 27 days ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing - GlobeNewsWire